The Female Health Company (NASDAQ-CM: FHCO) today announced a repurchase of 35,000 shares of its outstanding common stock under the Company's stock repurchase program. The program has a repurchase cap of three million shares of common stock and expires on December 31, 2014. The Company has repurchased approximately 2.1 million shares under the program, and approximately 0.9 million shares remain for potential repurchase.
The Company completed the repurchase of 35,000 shares of common stock on Monday, May 19, 2014. Management believes the Company's common stock is currently undervalued in the market and that the current share price does not reflect the Company's intrinsic value or its prospects for long-term growth in revenue and earnings. Future repurchases of shares may be considered when management believes it is in the best interests of shareholders.
Market Data 
Markets 
AI
